Court of Justice (Fourth Chamber) 19 July 2012, C‑130/11 (Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.)
Also known as
European Union · · · Cited by 63 · 19-07-2012
JUDGMENT OF THE COURT (Fourth Chamber) 19 July 2012 ( *1 ) ‛Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Article 3 — Conditions for obtaining a supplementary protection certificate — Medicinal product having obtained a valid marketing authorisation — First authorisation — Product successively authorised as a veterinary medicinal product
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (63 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit